 This 2nd edition of the Leishmaniasis East Africa Platform (LEAP) Newsletter provides insights into drug regulation in Kenya, capacity building, clinical trial updates, developments in the field of diagnostics for kala azar in Africa, and introduces the notion of good financial practices. »
|
|
|
A recent publication in Lancet Global Health by DNDi and colleagues showed that from 2000 to 2011 only 4% of all new drugs and vaccines approved were for neglected diseases. The data sets compiled for this analysis are now available open access. 
A Paediatric HIV Roundtable with Industry was hosted by DNDi in Dakar, Senegal, late last year, resulting in a call to action to expedite development of paediatric ARV formulations. The report also provides a snapshot of all paediatric ARVs developed or in development today.
